In the treatment of angina pectoris a double-blind evaluation of verapamil (Cordilox) at two dose levelsnamely, 80 mg thrice daily and 120 mg thrice dailypropranolol (Inderal) 100 mg thrice daily, and isosorbide dinitrate (Vascardin) 20 mg thrice daily has been made against a placebo. The assessment was based on relief from daily attacks of angina on effort and the response to a whole-body exercise test. We can find no statistically significant difference between the effects of verapamil (120 mg three times a day) and propranolol (100 mg three times a day) in the treatment of angina of effort. Both of these preparations are more effective than a placebo both in the reduction of daily attacks (P < 0-01) and in the prolongation of exercise test (P < 005). Isosorbide dinitrate (20 mg three times a day) appears to be no more effective than a placebo in the treatment of angina on effort, but 14 out of 32 patients experienced headache of such severity that even when the dose was reduced to 10 mg thrice daily this drug therapy had to be withdrawn. Both propranolol (100 mg three times a day) and verapamil (120 mg-three times a day) had a significant lowering effect on the diastolic blood pressure as measured with the patient standing (P < 0-01).
PAPERS AND ORIGINALS
Summary In the treatment of angina pectoris a double-blind evaluation of verapamil (Cordilox) at two dose levelsnamely, 80 mg thrice daily and 120 mg thrice dailypropranolol (Inderal) 100 mg thrice daily, and isosorbide dinitrate (Vascardin) 20 mg thrice daily has been made against a placebo. The assessment was based on relief from daily attacks of angina on effort and the response to a whole-body exercise test. We can find no statistically significant difference between the effects of verapamil (120 mg three times a day) and propranolol (100 mg three times a day) in the treatment of angina of effort. Both of these preparations are more effective than a placebo both in the reduction of daily attacks (P < 0-01) and in the prolongation of exercise test (P < 005). Isosorbide dinitrate (20 mg three times a day) appears to be no more effective than a placebo in the treatment of angina on effort, but 14 out of 32 patients experienced headache of such severity that even when the dose was reduced to 10 mg thrice daily this drug therapy had to be withdrawn. Both propranolol (100 mg three times a day) and verapamil (120 mg-three times a day) had a significant lowering effect on the diastolic blood pressure as measured with the patient standing (P < 0-01).
Introduction
The value of beta-adrenergic blocking agents in the management of angina on effort is well established (Alleyne et al., 1963; Hamer et al., 1964; Keelan, 1965) . However, not all patients with ischaemic heart disease benefit from beta-blockade because of the negatively inotropic effect of this type of therapy, and the search for other drugs in the treatment of angina pectoris has continued.
Verapamil, a derivative of papaverine, was discovered in 1963 and first used in the treatment of angina because of its coronary arterial dilator properties in experimental animals. Its exact mode of action is not known, but it can abolish the tachycardia induced by both isoprenaline and atropine (Oram et al., 1971) . Certainly verapamil does not act solely as a beta-blocker (Ross and Jorgensen, 1967) , nor does it have a quinidine-like action (Singh and Vaughan-Williams, 1972) . It has been suggested that as a calcium-ion antagonist it interferes with electromechanical coupling (Fleckenstein et al., 1968) . However, our experience suggests that in man an important action of verapamil is to augment the effect of vagal tone on the specialized conducting tissue of the heart (Livesley and Oram, 1972) . Tbhis action must be by direct effect, since Ross and Jorgensen (1967) showed that verapamil can produce bradycardia in cats even after vagotomy.
Verapamil has been used in the treatment of myocardial ischaemia (Phear, 1968; Sandler et al., 1968) , and it was the conflicting results of these reports which stimulated us to begin our comparative trial.
Isosorbide dinitrate is a popular antianginal agent, which probably acts by its vasodilator properties (Case et al., 1964; Goldstein et al., 1971) Banks and Shugoll (1967) (Holter, 1957; Bellet et al., 1962; Bellet and Muller, 1965; Magel et al., 1969) . The advantages of monitoring the E.C.G. during exercise are well recognized (Rosenfeld et al., 1964; Master, 1968) . A bipolar chest lead was recorded. The indifferent electrode was placed just below the suprasternal notch and the other electrode was placed in the V5 position. These sites were chosen following the work of Wood et al. (1950) and also because of their reproducibility in any particular patient. The electrodes were of the lightweight disposable type produced by Dracard Ltd. (Hubner, 1969) , and their socket, which connected with the transmitter, was fixed to the chest wall with Scotch tape to prevent the distortion which would otherwise have occurred on the record due to the patient's movement. The transmitter was carried in a belted pouch at the level of the patient's waist, and this allowed the patient to be completely mobile. The E.C.G. trace was displayed on an oscilloscope and recorded simultaneously on a Siemen's Cardiostat recorder. Although the patient was allowed to rest by sitting on a high chair the body trunk was erect at all times. No change was seen on the E.C.G. of any patient as the body position was changed from sitting to standing (Friesinger et al., 1965) . The time constant of the E.C.G. recorder was not prolonged when the telemetry apparatus was linked to the recorder (Gold, 1967) .
The exercise consisted of a simplified version of the large muscle mass exercise of Kaltenbach (1968) . For this modified procedure the patient stood holding a bar which was fixed to the wall above a step. The height of the step was adjusted so that when one foot was placed on the step the other remained on the floor with the patient's hip flexed to 900. At a signal the patient pulled himself up and placed both feet on the step and then stepped down again putting both feet on to the floor. The cycle was repeated continuously in time with a metronome, each click of the metronome being the time for one foot movement. A rate of 92 steps a minute had been selected by previous trial. When the patient was poised with both feet on the step and his body at maximal height he breasted the wall bars and his head just tipped an adjustable board situated above. The patient exercised until he wished to stop because of symptoms or until, in the highly motivated patient, the rhythm of the exercise became irregular.
The intention of this exercise was to produce a significant and sustained tachycardia. This stress test commonly produced heart rates in the range 180-200/min in 30 normal controls studied previously. The E.C.G. recorder used was a battery-driven model, and to allow accurate calculation of the patient's heart rate the paper speed was checked by introducing a 50 c.p.s. mains artefact on to the record. The heart rates were expressed as the mean of three consecutive R-R intervals measured in millimetres and were recorded during rest, at peak exercise, and after two and five minutes' rest.
Results
The results of the second fortnight of each treatment period are given in three times a day) and verapamil (120 mg three times daily) had a significant lowering effect (P < 0-01) on the diastolic blood pressure, as measured with the patient standing erect.
Discussion Evans and Hoyle (1933) reported a 38% improvement in a group of patients given only placebo treatment for angina pectoris. Even if a double-blind trial is undertaken a substantial number of patients may report improvement in both the trial and test periods when their conditions are unchanged (Mitchell, 1961) . It is therefore important to have not only an effective controlled trial of drugs considered for the treatment of angina but also a test period of adequate duration. In order to evaluate treatment it is important that the patient himself records the frequency of attacks and his trinitrin consumption during his daily activities, as therapy is being given to improve the quality of his daily life, which only he can assess.
Comparative assessment using an exercise tolerance test is an important adjunct to the investigation of the drug treatment of angina provided the conditions of the test are standardized. As a result of the conclusions of Wayne and Laplace (1933) the exercise test was arranged to occur under relatively constant conditions of recording time in the day, postcibal state, adequate pre-exercise rest, amount of clothing worn, and performance of the exercise at room temperature. The best exercise stress test is one involving whole-body muscle mass, and this can be easily and conveniently monitored by radiotelemetric E.C.G. control (Holter, 1957) . The exercise can be continued until the patient wishes to stop. The appearance of ischaemic S-T segment depression before the development of pain is not an indication for stopping the test, since he is doing "no more under close control than he is in the habit of doing several times a day without observation" (Wayne and Laplace, 1933) .
Depression of the S-T segment greater than 0 5 mm when measured 80 msec after the peak of the R wave was accepted as abnormal. However, it has never been proved that the depression of the S-T segment can be used to allow a linear quantitative assessment of the severity of myocardial ischaemia, although this has been assumed previously (Gianelly et al., 1969) . Indeed, during this trial 22 of the 32 patients did not develop abnormal S-T segment depression at the peak exercise stage in all of the three controlled exercise tests they performed. This absence of reproducibility encouraged us to ignore this finding in the evaluation of the trial.
Aerobic myocardial metabolism is dependent on the existence of a myocardial oxygen supply which is at least equal to if not in excess of its requirements. It is well recognized that as the heart rate rises the myocardial oxygen requirement also rises (Lange Andersen et al., 1970) . This relation is almost linear, and as the heart rate rises there is an increase in coronary blood flow (Forrester et al., 1971) . Advanced atherosclerosis involving the major coronary arteries will cause obstruction to coronary flow. Accordingly under these conditions the increase in volume of coronary flow required to provide for the increasing oxygen requirements of a heart beating more rapidly in response to exercise will not be able to occur. At a critical level of heart rate, and therefore at a critical level of body exercise, myocardial hypoxia will occur. This was confirmed by Balcon et al. (1969) in their observations on the critical tension time index required to precipitate angina in individual patients. Our results indicate that both propranoJol (100 mg three times a day) and verapamil (120 mg three times daily) significantly reduce the heart rate at rest and throughout the exercise test, and this action together with their hypotensive effects may account for the value of these preparations in the treatment of exercise-induced angina pectoris.
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